Synapse Open Synapse
Biology

Aspen raises a $141M IPO in pursuit of a cell therapy for Parkinson’s

BioPharma Dive · · 2 min read

The San Diego biotechnology startup is one of several firms working on a cutting-edge technique with the potential to slow or even halt the neurodegenerative condition.

Latest from BioPharma Dive